87 related articles for article (PubMed ID: 10235231)
1. Hepatitis C therapy: is it really worth it?
Johanson JF
Am J Gastroenterol; 1999 May; 94(5):1412-3. PubMed ID: 10235231
[No Abstract] [Full Text] [Related]
2. [Cost effectiveness of the treatment of chronic hepatitis C with interferon-alpha].
Buti M; Casado MA; Fosbrook L; Esteban R
Gastroenterol Hepatol; 1998 Apr; 21(4):161-8. PubMed ID: 9633175
[TBL] [Abstract][Full Text] [Related]
3. [Medico-economic assessment of the therapeutic management of patients with hepatitis C].
Loubière S; Rotily M; Moatti JP
Gastroenterol Clin Biol; 2000 Nov; 24(11):1047-51. PubMed ID: 11139674
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
Babu S
Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929872
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
Desai HG
Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929870
[No Abstract] [Full Text] [Related]
6. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
Nagral A
Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929871
[No Abstract] [Full Text] [Related]
7. Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries.
Aggarwal R; Ghoshal UC; Naik SR
Natl Med J India; 2002; 15(6):320-7. PubMed ID: 12540064
[TBL] [Abstract][Full Text] [Related]
8. Dynamic decision analysis to determine optimal treatment duration in chronic hepatitis C.
Veldt BJ; Hansen BE; Eijkemans MJ; de Knegt RJ; Stijnen T; Habbema JD; Schalm SW
Aliment Pharmacol Ther; 2005 Mar; 21(5):539-47. PubMed ID: 15740537
[TBL] [Abstract][Full Text] [Related]
9. Productivity improvements in hepatitis C treatment: impact on efficacy, cost, cost-effectiveness and quality of life.
Lidgren M; Hollander A; Weiland O; Jönsson B
Scand J Gastroenterol; 2007 Jul; 42(7):867-77. PubMed ID: 17558912
[TBL] [Abstract][Full Text] [Related]
10. [Economic evaluation of combined therapy in chronic hepatitis C].
Casado MA; Buti M; Fosbrook L; Esteban R
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():57-62. PubMed ID: 11968346
[No Abstract] [Full Text] [Related]
11. [Therapy of chronic hepatitis B and C].
Müllhaupt B; Renner EL
Praxis (Bern 1994); 1999 Apr; 88(14):619-32. PubMed ID: 10321122
[TBL] [Abstract][Full Text] [Related]
12. [Prolonged remission of chronic hepatitis C despite corticoid and immunosuppressive treatment].
Pariente A; Liversain JM; Briaud M; Texereau P
Gastroenterol Clin Biol; 1997; 21(8-9):635. PubMed ID: 9587508
[No Abstract] [Full Text] [Related]
13. [Chronic hepatitis C, autoimmunity and interferon alfa treatment].
Garcia Buey L; Moreno Otero R
Rev Esp Enferm Dig; 1999 Mar; 91(3):165-7. PubMed ID: 10348601
[No Abstract] [Full Text] [Related]
14. The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience.
Pojoga C; Dumitraşcu DL; Pascu O; Grigorescu M
J Gastrointestin Liver Dis; 2006 Mar; 15(1):31-5. PubMed ID: 16680230
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha for chronic hepatitis C: reducing the uncertainties.
Koff RS
Ann Intern Med; 1997 Nov; 127(10):918-20. PubMed ID: 9382371
[No Abstract] [Full Text] [Related]
16. Interferon in wonderland.
Koretz RL
Gastroenterology; 1998 Oct; 115(4):1027-9. PubMed ID: 9786731
[No Abstract] [Full Text] [Related]
17. [Chronic hepatitis. 3. An actual case].
Moradpour D; Blum HE
Dtsch Med Wochenschr; 2001 Jul; 126(27):789; quiz 790-2. PubMed ID: 11510460
[No Abstract] [Full Text] [Related]
18. Economics of chronic hepatitis B and hepatitis C.
Rajendra A; Wong JB
J Hepatol; 2007 Oct; 47(4):608-17. PubMed ID: 17697724
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States.
Brooks EA; Lacey LF; Payne SL; Miller DW
Am J Manag Care; 2001 Jul; 7(7):677-82. PubMed ID: 11464426
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
